Pnc Financial Services »

Diamedica Therapeutics shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1k 450 6.87

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Erie Indty Cl A (ERIE)
Amazon (AMZN)
Ishares Tr Rus 1000 Grw E (IWF)
Ishares Tr Core Msci Eafe (IEFA)
Wisdomtree Tr Us Qtly Div Gr (DGRW)

View all positions for Pnc Financial Services

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Millennium Management
Paragon Associates & Paragon Associates Ii Joint Venture
Geode Capital Management
Vanguard Group
First Manhattan
State Street Corporation
Bleichroeder
Northern Trust
Morgan Stanley
LPL Financial
Advisor Group Holdings
CI Private Wealth
Corient IA

View all funds holding Diamedica Therapeutics